|
CN112194730A
|
|
Polypeptide TI-16 and application thereof
|
|
CN112176064A
|
|
Application of ATXN7L3 in diagnosis, treatment and prognosis of liver cancer
|
|
CN112159849A
|
|
Diagnostic marker related to sarcoma radiotherapy resistance and application
|
|
CN112063721A
|
|
Application of MOF in liver cancer treatment
|
|
CN112010828A
|
|
CDK7 small-molecule inhibitor compound and application thereof
|
|
WO2021057942A1
|
|
Gene-engineered mesenchymal stem cells and applications thereof
|
|
CN112043722A
|
|
Use of PRPF6 in the treatment of prostate cancer and castration resistant prostate cancer
|
|
CN112063718A
|
|
Application of USP14 in diagnosis, prognosis and treatment of liver cancer
|
|
CN111973745A
|
|
Application of BAP18 in resisting endocrine treatment of breast cancer
|
|
CN111973610A
|
|
Application of tea saponin in preparing medicament for preventing or treating depression
|
|
CN111892660A
|
|
Polypeptide for constructing long QT syndrome animal model
|
|
CN111875695A
|
|
Polypeptide CM4-R and application thereof
|
|
CN111921016A
|
|
Artificial organ manufacturing mold and artificial organ manufacturing method
|
|
CN111701021A
|
|
Application of NIPA2 as drug target in preparation of drug for treating type 2 diabetes osteoporosis
|
|
CN111763670A
|
|
Targeted inhibitor of hsa _ circ _0008821 gene and application thereof
|
|
CN111493942A
|
|
Medical totally-enclosed pathological sampling device
|
|
CN111521474A
|
|
Method for detecting urea and creatinine in forensic hemolytic blood sample
|
|
CN111518171A
|
|
Polypeptide targeting human liver cancer cells and application thereof
|
|
CN111481320A
|
|
Special combined die for preparing complex organ and method for preparing liver precursor by using combined die
|
|
TW202038948A
|
|
Use of adam9 inhibitor as immune modulator
|
